FDA Inspection 1261263 — CSL Plasma Inc.

CSL Plasma Inc. — FEI 1000118483

The FDA completed an inspection of CSL Plasma Inc. on February 14, 2025 in Manhattan, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 14, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Manhattan, KS (United States)